Technology-enabled, data-driven Managed Access company RareiTi is pleased to announce that Heather Manna has joined the company as Director of Regulatory Affairs. In her new role, Manna is responsible for all aspects of the firm’s compliance program, and she offers clients critical expertise in managing the regulatory submission process for expanded access programs. “Expanded access is a rapidly evolving field, and Heather brings an expansive knowledge of the complex regulations that govern these programs,” noted RareiTi Chief Executive Officer Alex Evans. “The addition of Heather Manna underscores RareiTi’s commitment to being at the leading edge of access strategies globally.”
Heather’s career encompasses more than 20 years in regulatory affairs, compliance and program management in roles of increasing responsibility. Before joining RareiTi, Manna served as Head of US Operations for expanded access provider MyTomorrows. She has a long track record of involvement with all facets of the regulatory submission process from CTA through approved NDA for leading pharmaceutical developers including Takeda, Sanofi-Aventis and ImClone.
“I’m thrilled to be part of a leadership team that is so passionate about providing more patients with access to new treatments,” said Manna. “The firm’s commitment to the rare disease community and to supporting its Managed Access Programs with innovative technology have convinced me that RareiTi is leading the industry forward.”
RareiTi offers a new Managed Access model to the pharmaceutical industry delivering solutions to meet the unmet needs of people and communities across the globe impacted by rare disease. Our Managed Access and patient support programs provide care beyond therapy, combining customizable solutions with white glove service. We combine a breadth of global experience, cutting edge technologies and analytics that deliver better outcomes. To find out more, visit www.rareiti.com or email us at firstname.lastname@example.org.